IQIYI Inc - ADR vs Revolution Medicines Inc. Common Stock — how do they compare? IQIYI Inc - ADR trades at $1.02 (market cap $974.67M), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 41.4× IQIYI Inc - ADR's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, IQIYI Inc - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold IQIYI Inc - ADR for 55 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| IQ | RVMD | |
|---|---|---|
Market Cap | $974.67M | $40.32B |
Volume | 4,964,108 | 4,855,734 |
Sector | Media | Health |
52-Week High | $2.35 | $221.15 |
52-Week Low | $0.86 | $47.50 |
Typical Hold Time | 55 Days | 0 Days |
Enterprise Value | $2.47B | $37.02B |
Signals from Pluang's Aura AI — not financial advice
iQIYI (IQ) trades at $1.02, up 0.49% with bearish technical signals despite recent earnings beats. The company faces revenue contraction to $27.29B in 2025 and negative net margins (-3.22%), though valuation ratios like P/S (0.25) and P/B (0.52) appear attractive. Recent news highlights AI-driven content initiatives, including the successful 'The Ferry Man' series, as management pivots to offset streaming declines.
Outlook remains challenged by sustained losses and competitive pressures, but analyst consensus leans bullish (50% Buy ratings). Key risks include execution on AI content monetization and Chinese regulatory environment. The stock's deep value profile offers speculative appeal if operational turnaround materializes.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →